Microbicidal NO production is reliant on inducible NO synthaseâmediated l-arginine metabolism in macrophages (MΊs). However, l-arginine supply can be restricted by arginase activity, resulting in inefficient NO output and inhibition of antimicrobial MΊ function. MΊs circumvent this by converting l-citrulline to l-arginine, thereby resupplying substrate for NO production. In this article, we define the metabolic signature of mycobacteria-infected murine MΊs supplied l-arginine, l-citrulline, or both amino acids. Using liquid chromatographyâtandem mass spectrometry, we determined that l-arginine synthesized from l-citrulline was less effective as a substrate for arginase-mediated l-ornithine production compared with l-arginine directly imported from the extracellular milieu. Following Mycobacterium bovis bacillus CalmetteâGuĂ©rin infection and costimulation with IFN-Îł, we observed that MΊ arginase activity did not inhibit production of NO derived from l-citrulline, contrary to NO inhibition witnessed when MΊs were cultured in l-arginine. Furthermore, we found that arginase-expressing MΊs preferred l-citrulline over l-arginine for the promotion of antimycobacterial activity. We expect that defining the consequences of l-citrulline metabolism in MΊs will provide novel approaches for enhancing immunity, especially in the context of mycobacterial disease.